3 results
Approved WMOCompleted
The central hypothesis of this project is that Aliskiren causes a substantial decrease in MSNA in hypertensive patients with CKD.
Approved WMOCompleted
Primary objective: To evaluate local implementation, safety, feasibility and efficacy of temporary RV support with the Impella RP circulatory support deviceSecondary objective: -To evaluate the effect of temporary RV support on several clinical and…
Approved WMOWill not start
This study will evaluate the effectiveness and safety of a 36-week refill regimen for the PDS with ranibizumab 100 mg/mL (PDS Q36W) compared with intravitreal injections of aflibercept (2 mg) administered per a treat-and-extend regimen (aflibercept…